These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 9514463)

  • 1. Aggressive lipid lowering in postcoronary angioplasty patients with elevated cholesterol (the Lovastatin Restenosis Trial).
    Boccuzzi SJ; Weintraub WS; Kosinski AS; Roehm JB; Klein JL
    Am J Cardiol; 1998 Mar; 81(5):632-6. PubMed ID: 9514463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of effect of lovastatin on restenosis after coronary angioplasty. Lovastatin Restenosis Trial Study Group.
    Weintraub WS; Boccuzzi SJ; Klein JL; Kosinski AS; King SB; Ivanhoe R; Cedarholm JC; Stillabower ME; Talley JD; DeMaio SJ
    N Engl J Med; 1994 Nov; 331(20):1331-7. PubMed ID: 7935702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Establishing the benefit of statins in low-to-moderate--risk primary prevention: the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS).
    Gotto AM
    Atheroscler Suppl; 2007 Aug; 8(2):3-8. PubMed ID: 17588826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Background and methods for the lovastatin restenosis trial after percutaneous transluminal coronary angioplasty. The Lovastatin Restenosis Trial Study Group.
    Weintraub WS; Boccuzzi SJ; Brown CL; Cohen CL; Hirsch LJ; King SB; Alexander RW
    Am J Cardiol; 1992 Aug; 70(3):293-9. PubMed ID: 1632391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of restenosis after coronary balloon angioplasty: rationale and design of the Fluvastatin Angioplasty Restenosis (FLARE) Trial. The FLARE Study Group.
    Foley DP; Bonnier H; Jackson G; Macaya C; Shepherd J; Vrolix M; Serruys PW
    Am J Cardiol; 1994 May; 73(14):50D-61D. PubMed ID: 8198025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness analysis of simvastatin and lovastatin/extended- release niacin to achieve LDL and HDL goal using NHANES data.
    Armstrong EP; Zachry WM; Malone DC
    J Manag Care Pharm; 2004; 10(3):251-8. PubMed ID: 15228376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of lovastatin on progression of non-dilated and dilated coronary segments and on restenosis in patients after PTCA. The cholesterol lowering atherosclerosis PTCA trial (CLAPT).
    Kleemann A; Eckert S; von Eckardstein A; Lepper W; Schernikau U; Gleichmann U; Hanrath P; Fleck E; Neiss A; Kerber S; Assmann G; Breithardt G;
    Eur Heart J; 1999 Oct; 20(19):1393-406. PubMed ID: 10487800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of serum lipid concentrations on restenosis after successful de novo percutaneous transluminal coronary angioplasty in patients with total cholesterol 160 to 240 mg/dl and triglycerides < 350 mg/dl.
    Dzavik V; Teo KK; Yokoyama S; Modi R; Dinwoodie A; Burton JR; Tymchak WJ; Montague TJ
    Am J Cardiol; 1995 May; 75(14):936-8. PubMed ID: 7733005
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of increasing high-density lipoprotein cholesterol and decreasing low-density lipoprotein cholesterol on the incidence of first acute coronary events (from the Air Force/Texas Coronary Atherosclerosis Prevention Study).
    Cui Y; Watson DJ; Girman CJ; Shapiro DR; Gotto AM; Hiserote P; Clearfield MB
    Am J Cardiol; 2009 Sep; 104(6):829-34. PubMed ID: 19733719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events.
    Ridker PM; Rifai N; Clearfield M; Downs JR; Weis SE; Miles JS; Gotto AM;
    N Engl J Med; 2001 Jun; 344(26):1959-65. PubMed ID: 11430324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of lovastatin on early restenosis.
    Beigel Y; Zafrir N; Teplitzky Y; Neuman Y; Gavish D; Wurzel M; Fainaru M
    J Clin Pharmacol; 1995 Jun; 35(6):599-605. PubMed ID: 7665720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can aggressive lipid lowering using low-density lipoprotein apheresis prevent restenosis after percutaneous transluminal coronary angioplasty in patients with normocholesterolemia?
    Yamashita K; Tasaki H; Tsuda Y; Himeno E; Nakashima Y
    Ther Apher; 1998 Aug; 2(3):210-7. PubMed ID: 10227772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipid-lowering medications: what the new guidelines and data mean to women.
    Schwartz JB
    J Gend Specif Med; 2001; 4(2):9-13. PubMed ID: 11480105
    [No Abstract]   [Full Text] [Related]  

  • 14. Is aggressive cholesterol control justified? Review of the post-coronary artery bypass graft trial.
    Hunninghake DB
    Am J Cardiol; 1998 Nov; 82(10B):45T-48T. PubMed ID: 9860374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extending the benefit of lipid-regulating therapy to primary prevention.
    Jones PH; Gotto AM
    Am J Cardiol; 1995 Sep; 76(9):118C-121C. PubMed ID: 7572680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum lipids and restenosis after successful percutaneous transluminal coronary angioplasty. Ichilov Magnesium Study Group.
    Roth A; Eshchar Y; Keren G; Sheps D; Kerbal S; Laniado S; Miller HI; Rubinstein A
    Am J Cardiol; 1994 Jun; 73(16):1154-8. PubMed ID: 8203331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identifying patients at risk for coronary heart disease: implications from trials of lipid-lowering drug therapy.
    Isles CG; Paterson JR
    QJM; 2000 Sep; 93(9):567-74. PubMed ID: 10984551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness analysis of cholesterol-lowering therapies in Spain.
    Plans-Rubió P
    Am J Cardiovasc Drugs; 2006; 6(3):177-88. PubMed ID: 16780391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipid lowering in acute coronary syndromes: new evidence, new questions.
    Schwartz GG; Olsson AG
    Curr Atheroscler Rep; 2002 Jan; 4(1):1-3. PubMed ID: 11772415
    [No Abstract]   [Full Text] [Related]  

  • 20. Prevention of restenosis by lovastatin after successful coronary angioplasty.
    Sahni R; Maniet AR; Voci G; Banka VS
    Am Heart J; 1991 Jun; 121(6 Pt 1):1600-8. PubMed ID: 2035374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.